[250 Pages Report] The global organ transport devices market is set to reach a valuation of US$ 115.1 Million in 2022 and expand at a CAGR of 8.7% in the forecast period (2022-2032). The global market is projected to reach US$ 265.1 Million by the end of 2032.
| Attributes | Key Statistics |
|---|---|
| Global Organ Transport Devices Market Estimated Value (2022E) | US$ 115.1 Million |
| Projected Market Valuation (2032F) | US$ 265.1 Million |
| Value-based CAGR (2022 to 2032) | 8.7% |
| Collective Value Share: Top 5 Countries (2022E) | 55.2% |
The organ transport devices industry held approximately 51.4% of the global organ preservation market in 2021 which was worth US$ 206.1 Million.
Rising incidence of organ failure is expected to lead to increasing number of organ transplant surgeries performed around the world. Over the projected period, the market for organ transport devices is expected to grow at a fast pace due to increasing prevalence of chronic diseases.
Cardiovascular disorders, for instance, have become one of the leading causes of death and morbidity in the past three decades. According to the American Heart Association (AHA), in 2021, cardiovascular disease (CVD) affected about 92.1 million individuals in the U.S. and it is the leading cause of death in the country, as compared to other chronic conditions.
High prevalence of organ malfunction, especially of the kidney, liver, and heart, is becoming common among the geriatric population. According to the United States Government Information on Organ Donation and Transplantation, 63 per cent of those who received organ transplants in 2019 were 50 years or older, and 21% of all organ transplant patients were 65 years or older. These numbers are projected to grow rapidly in the assessment period, thereby driving demand for organ transport devices.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of organ transport devices have expanded in recent years owing to increased adoption of advanced devices and solutions. Various advantages of organ transport devices such as ease of transport and fast delivery of required organs at the right place, over other available devices in the market, is also set to push growth.
Over the forecast period, the market for organ transport devices is expected to be influenced by increased government initiatives to promote organ donation.
As per the National Kidney Foundation, at present, there are about 121,678 people waiting for lifesaving organ transplants in the U.S. Out of these, nearly 100,791 individuals are waiting for kidney transplants. Owing to the above-mentioned factors, sales of organ transport devices are projected to surge in the evaluation period.
In addition, several companies in the organ transport devices market are implementing a variety of organic strategies that would result in dynamic market improvements. They are mainly focusing on new product launches, product approvals, and development to increase sales.
For instance, TransMedics Group, Inc. received the U.S. FDA premarket approval for its OCS Liver System to preserve organs following DCD and DCBD in September 2021. The OCS Liver System would help preserve and observe metabolic and hemodynamics functions that would further enable ex-vivo assessment from DBD and DCD donor livers of liver allografts.
Spurred by the aforementioned factors, the global organ transport devices market is likely to grow at a CAGR of 8.7% from 2022 to 2032.
Governments of various countries worldwide are working to improve their healthcare infrastructures to deliver better services. Infrastructure improvement programs are set to help several hospitals to treat more brain-dead patients who may be acceptable donors.
Increasing establishment of testing laboratories and transplant centers across the globe is estimated to reduce the time spent on donor-recipient compatibility, subject profiling, genotyping, and other relevant diagnostic procedures during organ transplantations.
In addition, the industry will be boosted by increased risk of organ failure among patients suffering from chronic diseases. As per the WHO, about 34.2 million people in the U.S. are currently living with diabetes. Rising prevalence of diabetes is anticipated to result in kidney failures, thereby providing new opportunities to key players from 2022 to 2032.
Principal Consultant
Currently, there is a considerable disparity between the number of organs donated and those required. In the U.S., there were over 100,000 people on the organ transplant waiting list as of January 2022. By the end of 2021, only 41,354 transplants had been completed. The low number of organs donated each year is primarily owing to lack of organ donation awareness, ineffective legislative measures, and increased risk of organ trafficking.
Governments of various countries are also implementing reformed regulations such as opt-out laws that imply every citizen is an organ donor unless exempted and campaigns to encourage people to donate organs. However, these regulations are hampering growth in the organ transport devices market as there is a discrepancy between expected improved deceased organ donations and actual rates of deceased organ donations.
“Rising Prevalence of Organ Failure to Push the U.S. Market”
The U.S. held about 92.4% of the North America organ transport devices market share in 2021 and is expected to lead throughout the forecast period. The U.S. is considered to be the most lucrative market for organ transport devices owing to high prevalence rate of chronic disorders in the country.
Increasing cases of kidney failure in the U.S. on the back of diabetes and high blood pressure is projected to aid growth. It is further set to push the need for organ transplantation procedures and thus propel the U.S. market.
“Surging Number of Transplant Surgeries to Drive the U.K. Market”
The U.K. generated a share of approximately 20.2% in 2021 in the Europe organ transport devices market. Growth is attributed to increasing procedural rate of organ transplantation in the country.
According to the NHS 2019 Report, over 8,740 liver transplants were reported in the U.K. during the past ten years. On account of this, use of organ transport devices is projected to grow in the forthcoming years, thereby driving the U.K. market.
“Chronic Diseases among Geriatric Population to Push Growth”
China held around 57.4% share in the East Asia organ transport devices market in 2021 and is projected to grow at a rapid pace during the forecast period. Growth is attributed to increasing technological advancements in the field of organ transport in the country. Also, rising geriatric population is expected to augment growth in China.
As per the WHO, in 2019, there were 176 million older individuals belonging to the age group of 65 years or older and nearly 254 million people who were 60 years of age or older. Hence, the market for organ transport devices is expected to grow rapidly in China because of high risk of organ failure among the aging population.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Use of Hypothermic Perfusion Devices to Grow for Kidney Preservation Process”
Based on product, the cold or hypothermic perfusion devices segment is projected to showcase lucrative growth in the evaluation period. The segment held a share of 63.7% in 2021 in the global organ transport devices market.
Hypothermia is widely used and regarded as the gold standard treatment for organ preservation. Kidneys, liver, lungs, pancreas, and heart are all preserved with this method across the globe, which would push its demand in the next decade.
“Number of Kidney Transplant Surgeries to Grow in 2022-2032”
In terms of organ, the kidney segment held a revenue share of 62.0% in 2021 and is expected to grow at a considerable pace over the forecast period with a CAGR of 8.5%. Increasing number of kidney transplantation procedures across the globe with rising prevalence of chronic kidney disease and subsequent kidney failure is projected to boost the segment.
According to the CDC, chronic kidney disease affects nearly 15.0 per cent of adults in the U.S. each year. Thus, increasing number of kidney transplantation procedures is set to spur the use of novel organ transport devices.
“Transplant Centers to Adopt New Organ Transport Devices”
Based on end user, the transplant centers segment held about 67.4% of the organ transport devices market share in 2021. Increasing number of transplant centers around the world is a major factor that is projected to drive the segment. Governments of various countries are likely to invest in the enhancement of healthcare infrastructure, which would also push the segment.
Key players in the organ transport devices market are focusing on expanding their presence globally and are striving to broaden their product offerings to gain a competitive edge.
Meanwhile, some of the other companies are engaging in mergers, acquisitions, agreements, and collaborations to improve their existing product portfolios. They are also aiming to expand their manufacturing capacities to generate more shares.
Some of the recent developments in the global organ transport devices market are:
| Attributes | Details |
|---|---|
| Estimated Market Size (2022) | US$ 115.1 Million |
| Projected Market Valuation (2032) | US$ 265.1 Million |
| Value-based CAGR (2022 to 2032) | 8.7% |
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and the Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, India, Thailand, Indonesia, Malaysia, China, Japan, South Korea, Australia, New Zealand, GCC countries, Turkey, and North Africa. |
| Key Market Segments Covered | Products, Organ, End User, and Region |
| Key Companies Profiled | TransMedics Inc.; Paragonix Technologies; Organ Recovery Systems; XVIVO Perfusion AB; OrganOx Limited; X-Therma Inc.; Bridge to Life; French Institut Georges Lopez (IGL); EBERS Medical Technology SL. (Spain); Vascular Perfusion Solutions (USA); tritec®; B Medical Systems; LMB Technologie GmbH |
| Report Coverage | Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives |
The global organ transport devices market was worth US$ 105.9 Mn in 2021 and is set to expand 2.3x over the next ten years.
The organ transport devices market is expected to reach US$ 265.1 Mn by the end of 2032 and register a CAGR of 8.7% in 2022-2032.
Favorable government regulations, ongoing developments in the field of organ preservation devices, and growing R&D activities for the development of cost-effective services are some of the key trends shaping the organ transport devices industry.
The U.S., China, the U.K., Germany, and Japan are expected to drive demand for organ transport devices.
The U.S. accounted for nearly 92.4% of the North America organ transport devices market in 2021.
The Europe organ transport devices market is expected to register growth at a CAGR of 8.9% over the next ten years.
The U.S., Germany, and China are key producers of organ transport devices.
TransMedics Inc., Paragonix Technologies, Organ Recovery Systems, XVIVO Perfusion AB, OrganOx Limited, X-Therma Inc., Bridge to Life, and French Institut Georges Lopez (IGL) are the key organ transport devices manufacturers.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Innovation / Development Trends 4. Key Success Factors 4.1. Regulatory Landscape 4.2. Pipeline Assessment 4.3. New Products Launches & Approvals 4.4. Product Adoption / Usage Analysis 4.5. Key Strategies Adopted by market players 4.6. Porter’s Analysis 4.7. PESTLE Analysis 5. COVID-19 Crisis Analysis 5.1. 2021 Market Scenario 5.2. COVID-19 and Impact Analysis 5.2.1. Revenue By Product 5.2.2. Revenue By Organ 5.2.3. Revenue By End User 5.2.4. Revenue By Country 6. Market Background 6.1. Macro-Economic Factors 6.1.1. Global GDP Growth Outlook 6.1.2. Global Healthcare Spending Outlook 6.2. Forecast Factors - Relevance & Impact 6.2.1. Top companies’ historical growth 6.2.2. Pipeline products 6.2.3. New product launches and approvals 6.2.4. Cost of the products 6.2.5. Historic and current revenue of key players 6.2.6. Strategic developments by key players 6.2.7. New product approvals 6.2.8. Technology advancements in devices 6.3. Market Dynamics 6.3.1. Drivers 6.3.2. Restraints 6.3.3. Opportunity Analysis 7. Global Organ Transport Devices Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032 7.1. Historical Market Volume (Units) Analysis, 2017–2021 7.2. Current and Future Market Volume (Units) (Units) Projections, 2022–2032 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Organ Transport Devices Market - Pricing Analysis 8.1. Regional Pricing Analysis By Product 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Organ Transport Devices Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032 9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021 9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032, By Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2017–2021 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032 10.3.1. Warm or Normothermic Perfusion Devices 10.3.2. Cold or Hypothermic Perfusion Devices 10.4. Market Attractiveness Analysis By Product 11. Global Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032, By Organ 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Organ, 2017–2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Organ, 2022–2032 11.3.1. Liver 11.3.2. Heart 11.3.3. Kidney 11.3.4. Lung 11.3.5. Others (pancreas, small intestine) 11.4. Market Attractiveness Analysis By Organ 12. Global Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032, By End User 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032 12.3.1. Hospitals 12.3.2. Transplant Centers 12.3.3. Ambulatory Surgical Centers 12.4. Market Attractiveness Analysis By End User 13. Global Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2017–2021 13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Region, 2022–2032 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East & Africa 13.4. Market Attractiveness Analysis By Region 14. North America Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2021 14.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032 14.4.1. By Country 14.4.1.1. U.S. 14.4.1.2. Canada 14.4.2. By Product 14.4.3. By Organ 14.4.4. By End User 14.5. Market Attractiveness Analysis 14.5.1. By Product 14.5.2. By Organ 14.5.3. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 14.9. Country Level Analysis & Forecast 14.9.1. U.S. Organ Transport Devices Market 14.9.1.1. Introduction 14.9.1.2. Market Analysis and Forecast by Market Taxonomy 14.9.1.2.1. By Product 14.9.1.2.2. By Organ 14.9.1.2.3. By End User 14.9.2. Canada Organ Transport Devices Market 14.9.3. Introduction 14.9.4. Market Analysis and Forecast by Market Taxonomy 14.9.4.1.1. By Product 14.9.4.1.2. By Organ 14.9.4.1.3. By End User 15. Latin America Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2021 15.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032 15.4.1. By Country 15.4.1.1. Brazil 15.4.1.2. Mexico 15.4.1.3. Argentina 15.4.1.4. Rest of Latin America 15.4.2. By Product 15.4.3. By Organ 15.4.4. By End User 15.5. Market Attractiveness Analysis 15.5.1. By Product 15.5.2. By Organ 15.5.3. By End User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 15.9. Country Level Analysis & Forecast 15.9.1. Brazil Organ Transport Devices Market 15.9.1.1. Introduction 15.9.1.2. Market Analysis and Forecast by Market Taxonomy 15.9.1.2.1. By Product 15.9.1.2.2. By Organ 15.9.1.2.3. By End User 15.9.2. Mexico Organ Transport Devices Market 15.9.2.1. Introduction 15.9.2.2. Market Analysis and Forecast by Market Taxonomy 15.9.2.2.1. By Product 15.9.2.2.2. By Organ 15.9.2.2.3. By End User 15.9.3. Argentina Organ Transport Devices Market 15.9.4. Introduction 15.9.5. Market Analysis and Forecast by Market Taxonomy 15.9.5.1.1. By Product 15.9.5.1.2. By Organ 15.9.5.1.3. By End User 16. Europe Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2021 16.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032 16.4.1. By Country 16.4.1.1. Germany 16.4.1.2. Italy 16.4.1.3. France 16.4.1.4. U.K. 16.4.1.5. Spain 16.4.1.6. BENELUX 16.4.1.7. Russia 16.4.1.8. Rest of Europe 16.4.2. By Product 16.4.3. By Organ 16.4.4. By End User 16.5. Market Attractiveness Analysis 16.5.1. By Product 16.5.2. By Organ 16.5.3. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 16.9. Country Level Analysis & Forecast 16.9.1. Germany Organ Transport Devices Market 16.9.1.1. Introduction 16.9.1.2. Market Analysis and Forecast by Market Taxonomy 16.9.1.2.1. By Product 16.9.1.2.2. By Organ 16.9.1.2.3. By End User 16.9.2. Italy Organ Transport Devices Market 16.9.2.1. Introduction 16.9.2.2. Market Analysis and Forecast by Market Taxonomy 16.9.2.2.1. By Product 16.9.2.2.2. By Organ 16.9.2.2.3. By End User 16.9.3. France Organ Transport Devices Market 16.9.3.1. Introduction 16.9.3.2. Market Analysis and Forecast by Market Taxonomy 16.9.3.2.1. By Product 16.9.3.2.2. By Organ 16.9.3.2.3. By End User 16.9.4. U.K. Organ Transport Devices Market 16.9.4.1. Introduction 16.9.4.2. Market Analysis and Forecast by Market Taxonomy 16.9.4.2.1. By Product 16.9.4.2.2. By Organ 16.9.4.2.3. By End User 16.9.5. Spain Organ Transport Devices Market 16.9.5.1. Introduction 16.9.5.2. Market Analysis and Forecast by Market Taxonomy 16.9.5.2.1. By Product 16.9.5.2.2. By Organ 16.9.5.2.3. By End User 16.9.6. BENELUX Organ Transport Devices Market 16.9.6.1. Introduction 16.9.6.2. Market Analysis and Forecast by Market Taxonomy 16.9.6.2.1. By Product 16.9.6.2.2. By Organ 16.9.6.2.3. By End User 16.9.7. Russia Organ Transport Devices Market 16.9.7.1. Introduction 16.9.7.2. Market Analysis and Forecast by Market Taxonomy 16.9.7.2.1. By Product 16.9.7.2.2. By Organ 16.9.7.2.3. By End User 17. South Asia Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2021 17.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032 17.4.1. By Country 17.4.1.1. India 17.4.1.2. Thailand 17.4.1.3. Indonesia 17.4.1.4. Malaysia 17.4.1.5. Rest of South Asia 17.4.2. By Product 17.4.3. By Organ 17.4.4. By End User 17.5. Market Attractiveness Analysis 17.5.1. By Product 17.5.2. By Organ 17.5.3. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 17.9. Country Level Analysis & Forecast 17.9.1. India Organ Transport Devices Market 17.9.1.1. Introduction 17.9.1.2. Market Analysis and Forecast by Market Taxonomy 17.9.1.2.1. By Product 17.9.1.2.2. By Organ 17.9.1.2.3. By End User 17.9.2. Thailand Organ Transport Devices Market 17.9.2.1. Introduction 17.9.2.2. Market Analysis and Forecast by Market Taxonomy 17.9.2.2.1. By Product 17.9.2.2.2. By Organ 17.9.2.2.3. By End User 17.9.3. Indonesia Organ Transport Devices Market 17.9.3.1. Introduction 17.9.3.2. Market Analysis and Forecast by Market Taxonomy 17.9.3.2.1. By Product 17.9.3.2.2. By Organ 17.9.3.2.3. By End User 17.9.4. Malaysia Organ Transport Devices Market 17.9.4.1. Introduction 17.9.4.2. Market Analysis and Forecast by Market Taxonomy 17.9.4.2.1. By Product 17.9.4.2.2. By Organ 17.9.4.2.3. By End User 18. East Asia Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2021 18.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032 18.4.1. By Country 18.4.1.1. China 18.4.1.2. Japan 18.4.1.3. South Korea 18.4.2. By Product 18.4.3. By Organ 18.4.4. By End User 18.5. Market Attractiveness Analysis 18.5.1. By Product 18.5.2. By Organ 18.5.3. By End User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 18.9. Country Level Analysis & Forecast 18.9.1. China Organ Transport Devices Market 18.9.1.1. Introduction 18.9.1.2. Market Analysis and Forecast by Market Taxonomy 18.9.1.2.1. By Product 18.9.1.2.2. By Organ 18.9.1.2.3. By End User 18.9.2. Japan Organ Transport Devices Market 18.9.2.1. Introduction 18.9.2.2. Market Analysis and Forecast by Market Taxonomy 18.9.2.2.1. By Product 18.9.2.2.2. By Organ 18.9.2.2.3. By End User 18.9.3. South Korea Organ Transport Devices Market 18.9.3.1. Introduction 18.9.3.2. Market Analysis and Forecast by Market Taxonomy 18.9.3.2.1. By Product 18.9.3.2.2. By Organ 18.9.3.2.3. By End User 19. Oceania Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2021 19.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032 19.4.1. By Country 19.4.1.1. Australia 19.4.1.2. New Zealand 19.4.2. By Product 19.4.3. By Organ 19.4.4. By End User 19.5. Market Attractiveness Analysis 19.5.1. By Product 19.5.2. By Organ 19.5.3. By End User 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 19.9. Country Level Analysis & Forecast 19.9.1. Australia Organ Transport Devices Market 19.9.1.1. Introduction 19.9.1.2. Market Analysis and Forecast by Market Taxonomy 19.9.1.2.1. By Product 19.9.1.2.2. By Organ 19.9.1.2.3. By End User 19.9.2. New Zealand Organ Transport Devices Market 19.9.2.1. Introduction 19.9.2.2. Market Analysis and Forecast by Market Taxonomy 19.9.2.2.1. By Product 19.9.2.2.2. By Organ 19.9.2.2.3. By End User 20. Middle East and Africa Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032 20.1. Introduction 20.2. Pricing Analysis 20.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2021 20.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032 20.4.1. By Country 20.4.1.1. GCC Countries 20.4.1.2. Turkey 20.4.1.3. North Africa 20.4.1.4. South Africa 20.4.1.5. Rest of Middle East and Africa 20.4.2. By Product 20.4.3. By Organ 20.4.4. By End User 20.5. Market Attractiveness Analysis 20.5.1. By Product 20.5.2. By Organ 20.5.3. By End User 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 20.9. Country Level Analysis & Forecast 20.9.1. GCC Countries Organ Transport Devices Market 20.9.1.1. Introduction 20.9.1.2. Market Analysis and Forecast by Market Taxonomy 20.9.1.2.1. By Product 20.9.1.2.2. By Organ 20.9.1.2.3. By End User 20.9.2. Turkey Organ Transport Devices Market 20.9.2.1. Introduction 20.9.2.2. Market Analysis and Forecast by Market Taxonomy 20.9.2.2.1. By Product 20.9.2.2.2. By Organ 20.9.2.2.3. By End User 20.9.3. North Africa Organ Transport Devices Market 20.9.3.1. Introduction 20.9.3.2. Market Analysis and Forecast by Market Taxonomy 20.9.3.2.1. By Product 20.9.3.2.2. By Organ 20.9.3.2.3. By End User 20.9.4. South Africa Organ Transport Devices Market 20.9.4.1. Introduction 20.9.4.2. Market Analysis and Forecast by Market Taxonomy 20.9.4.2.1. By Product 20.9.4.2.2. By Organ 20.9.4.2.3. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 21.3.1. By Regional footprint of Players 21.3.2. Product foot print by Players 21.3.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. TransMedics Inc. 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Sales Footprint 22.3.1.4. Key Financials 22.3.1.5. SWOT Analysis 22.3.1.6. Strategy Overview 22.3.1.6.1. Marketing Strategy 22.3.1.6.2. Product Strategy 22.3.1.6.3. Channel Strategy 22.3.2. Paragonix Technologies 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Sales Footprint 22.3.2.4. Key Financials 22.3.2.5. SWOT Analysis 22.3.2.6. Strategy Overview 22.3.2.6.1. Marketing Strategy 22.3.2.6.2. Product Strategy 22.3.2.6.3. Channel Strategy 22.3.3. Organ Recovery Systems 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Sales Footprint 22.3.3.4. Key Financials 22.3.3.5. SWOT Analysis 22.3.3.6. Strategy Overview 22.3.3.6.1. Marketing Strategy 22.3.3.6.2. Product Strategy 22.3.3.6.3. Channel Strategy 22.3.4. XVIVO Perfusion AB 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Sales Footprint 22.3.4.4. Key Financials 22.3.4.5. SWOT Analysis 22.3.4.6. Strategy Overview 22.3.4.6.1. Marketing Strategy 22.3.4.6.2. Product Strategy 22.3.4.6.3. Channel Strategy 22.3.5. OrganOx Limited 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Sales Footprint 22.3.5.4. Key Financials 22.3.5.5. SWOT Analysis 22.3.5.6. Strategy Overview 22.3.5.6.1. Marketing Strategy 22.3.5.6.2. Product Strategy 22.3.5.6.3. Channel Strategy 22.3.6. X-Therma Inc. 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Sales Footprint 22.3.6.4. Key Financials 22.3.6.5. SWOT Analysis 22.3.6.6. Strategy Overview 22.3.6.6.1. Marketing Strategy 22.3.6.6.2. Product Strategy 22.3.6.6.3. Channel Strategy 22.3.7. Bridge to Life 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Sales Footprint 22.3.7.4. Key Financials 22.3.7.5. SWOT Analysis 22.3.7.6. Strategy Overview 22.3.7.6.1. Marketing Strategy 22.3.7.6.2. Product Strategy 22.3.7.6.3. Channel Strategy 22.3.8. French Institut Georges Lopez (IGL) 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Sales Footprint 22.3.8.4. Key Financials 22.3.8.5. SWOT Analysis 22.3.8.6. Strategy Overview 22.3.8.6.1. Marketing Strategy 22.3.8.6.2. Product Strategy 22.3.8.6.3. Channel Strategy 22.3.9. EBERS Medical Technology SL. (Spain) 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Sales Footprint 22.3.9.4. Key Financials 22.3.9.5. SWOT Analysis 22.3.9.6. Strategy Overview 22.3.9.6.1. Marketing Strategy 22.3.9.6.2. Product Strategy 22.3.9.6.3. Channel Strategy 22.3.10. Vascular Perfusion Solutions (US) 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Sales Footprint 22.3.10.4. Key Financials 22.3.10.5. SWOT Analysis 22.3.10.6. Strategy Overview 22.3.10.6.1. Marketing Strategy 22.3.10.6.2. Product Strategy 22.3.10.6.3. Channel Strategy 22.3.11. tritec® 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Sales Footprint 22.3.11.4. Key Financials 22.3.11.5. SWOT Analysis 22.3.11.6. Strategy Overview 22.3.11.6.1. Marketing Strategy 22.3.11.6.2. Product Strategy 22.3.11.6.3. Channel Strategy 22.3.12. B Medical Systems 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Sales Footprint 22.3.12.4. Key Financials 22.3.12.5. SWOT Analysis 22.3.12.6. Strategy Overview 22.3.12.6.1. Marketing Strategy 22.3.12.6.2. Product Strategy 22.3.12.6.3. Channel Strategy 22.3.13. Lmb Technologie GmbH 22.3.13.1. Overview 22.3.13.2. Product Portfolio 22.3.13.3. Sales Footprint 22.3.13.4. Key Financials 22.3.13.5. SWOT Analysis 22.3.13.6. Strategy Overview 22.3.13.6.1. Marketing Strategy 22.3.13.6.2. Product Strategy 22.3.13.6.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Organ Transport Devices Market
